This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Evolva Sa. Active years: 2013-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2016
Title: Melya Hughes Crameri: Innovator in Pharmaceutical Modulation
Introduction
Melya Hughes Crameri is a notable inventor based in Los Altos, CA. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate PPAR (Peroxisome Proliferator-Activated Receptor) activity. His work is crucial in addressing various diseases, including diabetes and cancer.
Latest Patents
Melya holds 2 patents that focus on substituted 1,3-dioxanes useful as PPAR modulators. These patents describe specifically useful stereoisomers of 1,3-dioxane derivatives and their applications in treating diseases dependent on PPAR modulation. This includes conditions such as diabetes, cancer, inflammation, neurodegenerative disorders, and infections. Additionally, these compounds are relevant in the treatment of diseases related to TP, such as cardiovascular diseases.
Career Highlights
Melya is currently associated with Evolva SA, where he continues to innovate and develop new therapeutic solutions. His expertise in the field has positioned him as a key player in pharmaceutical research and development.
Collaborations
Melya collaborates with talented professionals, including Jean-Philippe Meyer and Alexandra Santana Sorensen, to advance his research and patent applications.
Conclusion
Melya Hughes Crameri's contributions to the field of pharmaceutical modulation through his innovative patents highlight his commitment to improving health outcomes. His work continues to pave the way for new treatments for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile